UPDATE: Piper Sandler Starts Xeris Pharmaceuticals (XERS) at Overweight
Tweet Send to a Friend
(Updated - February 18, 2020 7:48 AM EST)
(updating comment)Piper Sandler analyst David Amsellem initiates coverage on Xeris Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Piper Sandler analyst David Amsellem initiates coverage on Xeris Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
